|Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR|
VM Corman, O Landt, M Kaiser, R Molenkamp, A Meijer, DKW Chu, ...
Eurosurveillance 25 (3), 2000045, 2020
|Commentary: Middle east respiratory syndrome coronavirus (mers-cov): announcement of the coronavirus study group|
RJ De Groot, SC Baker, RS Baric, CS Brown, C Drosten, L Enjuanes, ...
Journal of virology 87 (14), 7790-7792, 2013
|Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome|
T Kuiken, RAM Fouchier, M Schutten, GF Rimmelzwaan, ...
The Lancet 362 (9380), 263-270, 2003
|Mortality and pulmonary complications in patients undergoing surgery with perioperative SARS-CoV-2 infection: an international cohort study|
D Nepogodiev, A Bhangu, JC Glasbey, E Li, OM Omar, JFF Simoes, ...
The Lancet 396 (10243), 27-38, 2020
|Incidence of 2009 pandemic influenza A H1N1 infection in England: a cross-sectional serological study|
E Miller, K Hoschler, P Hardelid, E Stanford, N Andrews, M Zambon
The Lancet 375 (9720), 1100-1108, 2010
|Detection of a novel human coronavirus by real-time reverse-transcription polymerase chain reaction|
VM Corman, I Eckerle, T Bleicker, A Zaki, O Landt, M Eschbach-Bludau, ...
Eurosurveillance 17 (39), 20285, 2012
|Severe respiratory illness caused by a novel coronavirus, in a patient transferred to the United Kingdom from the Middle East, September 2012|
A Bermingham, MA Chand, CS Brown, E Aarons, C Tong, C Langrish, ...
Eurosurveillance 17 (40), 20290, 2012
|Safety and antigenicity of non-adjuvanted and MF59-adjuvanted influenza A/Duck/Singapore/97 (H5N3) vaccine: a randomised trial of two potential vaccines against H5N1 influenza|
KG Nicholson, AE Colegate, A Podda, I Stephenson, J Wood, E Ypma, ...
The Lancet 357 (9272), 1937-1943, 2001
|Safety and immunogenicity of an inactivated split-virion influenza A/Vietnam/1194/2004 (H5N1) vaccine: phase I randomised trial|
JL Bresson, C Perronne, O Launay, C Gerdil, M Saville, J Wood, ...
The Lancet 367 (9523), 1657-1664, 2006
|Oseltamivir-resistant influenza virus A (H1N1), Europe, 2007–08 season|
A Meijer, A Lackenby, O Hungnes, B Lina, S Van Der Werf, B Schweiger, ...
Emerging infectious diseases 15 (4), 552, 2009
|Contribution of influenza and respiratory syncytial virus to community cases of influenza-like illness: an observational study|
MC Zambon, JD Stockton, JP Clewley, DM Fleming
The Lancet 358 (9291), 1410-1416, 2001
|Duration of infectiousness and correlation with RT-PCR cycle threshold values in cases of COVID-19, England, January to May 2020|
A Singanayagam, M Patel, A Charlett, JL Bernal, V Saliba, J Ellis, ...
Eurosurveillance 25 (32), 2001483, 2020
|Detection of influenza viruses resistant to neuraminidase inhibitors in global surveillance during the first 3 years of their use|
AS Monto, JL McKimm-Breschkin, C Macken, AW Hampson, A Hay, ...
Antimicrobial agents and chemotherapy 50 (7), 2395-2402, 2006
|Unexpected receptor functional mimicry elucidates activation of coronavirus fusion|
AC Walls, X Xiong, YJ Park, MA Tortorici, J Snijder, J Quispe, E Cameroni, ...
Cell 176 (5), 1026-1039. e15, 2019
|Effectiveness of Covid-19 vaccines against the B. 1.617. 2 (Delta) variant.|
J Lopez Bernal, N Andrews, C Gower, E Gallagher, R Simmons, ...
N Engl J Med, 585-594, 2021
|Human metapneumovirus as a cause of community-acquired respiratory illness|
J Stockton, I Stephenson, D Fleming, M Zambon
Emerging infectious diseases 8 (9), 897, 2002
|Neuraminidase sequence analysis and susceptibilities of influenza virus clinical isolates to zanamivir and oseltamivir|
J McKimm-Breschkin, T Trivedi, A Hampson, A Hay, A Klimov, M Tashiro, ...
Antimicrobial agents and chemotherapy 47 (7), 2264-2272, 2003
|Emergence of resistance to oseltamivir among influenza A (H1N1) viruses in Europe|
A Lackenby, O Hungnes, SG Dudman, A Meijer, WJ Paget, AJ Hay, ...
Eurosurveillance 13 (5), 3-4, 2008
|Comparative community burden and severity of seasonal and pandemic influenza: results of the Flu Watch cohort study|
AC Hayward, EB Fragaszy, A Bermingham, L Wang, A Copas, ...
The Lancet Respiratory Medicine 2 (6), 445-454, 2014
|Multiplex PCR for typing and subtyping influenza and respiratory syncytial viruses|
J Stockton, JS Ellis, M Saville, JP Clewley, MC Zambon
Journal of clinical microbiology 36 (10), 2990-2995, 1998